Top Institutions in Ophthalmology - Retina
Leading academic medical centers and research institutions with strong ophthalmology and retina subspecialty programs have conducted pivotal clinical trials and long-term studies on anti-VEGF therapies and innovative drug delivery systems like Susvimo. These institutions have extensive experience in retinal disease clinical trials, imaging, and patient outcomes research.
-
#100
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a world leader in retinal disease research and clinical trials, including anti-VEGF therapies and novel drug delivery systems. Their faculty have been principal investigators in landmark nAMD studies and have pioneered advanced retinal imaging techniques.
-
#92
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is consistently ranked as a top ophthalmology center with a strong focus on retinal diseases and clinical trials for nAMD. They have contributed significantly to understanding long-term outcomes of anti-VEGF treatments and innovative therapies.
-
#88
Wills Eye Hospital
Philadelphia, PA
Wills Eye Hospital has a renowned retina service with extensive experience in clinical trials for neovascular AMD and anti-VEGF therapies. Their research includes long-term patient outcomes and novel treatment delivery methods.
-
#85
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is a leader in translational research and clinical trials for retinal diseases, including nAMD. They have contributed to the development and evaluation of sustained drug delivery systems and anti-VEGF therapies.
-
#82
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF has a robust ophthalmology department with a focus on retinal diseases and clinical trials. They have contributed to research on long-term outcomes of anti-VEGF therapy and innovative treatment modalities for nAMD.